Global Market Access

Conquer Global Barriers: Strategic Market Access and Commercial Growth

Expanding your health technology globally means facing a maze of regulations, complex procurement systems, and specialised pricing dynamics. The pain of delayed entry, compliance failure, or mispriced products can cripple international growth.

We provide the strategic alignment and tactical expertise to ensure your innovation successfully enters and thrives in major global markets—from the U.S. and EU to Asia-Pacific.

De-Risk Global Expansion: Compliance and Regulatory Alignment

Stop letting complex international rules slow your growth. We give you the clear compliance path to access new territories quickly and safely.

Global Regulatory Clearance: We support your business in aligning with critical healthcare regulations across key markets (U.S. FDA, Australia TGA, Japan PMDA, China NMPA, India CDSCO, Health Canada, etc.).
Data and Risk Mitigation: We ensure you demonstrate compliance with post-market surveillance and essential data regulations like HIPAA (U.S.) and GDPR (EU). Proactively managing these areas reduces risk and builds payer trust.

In partnership with our Medical Regulatory and Compliance Partners we can support you to achieve alignment in global markets to scale and grow your business quickly.

Master NHS Procurement and Secure Adoption

The NHS has multiple, complex entry points at national, regional and local level —from national government tenders and frameworks to local approaches via Integrated Care Boards (ICBs) and NHS Trusts. The pain is wasting time pursuing the wrong pathway or failing to meet strict documentation requirements.

We provide comprehensive support to navigate this system:

Targeted Pathway Strategy: We help you identify and access the most relevant route for your product: Government/NHS Tenders, NHS Supply Chain, regional approaches or direct engagement with ICBs and Trusts.
Tender Expertise: We guide you through accessing relevant portals (e.g., Contracts Finder, Find a Tender), meeting pre-qualification and compliance standards, and ensuring all required documentation—from product efficacy evidence, health economic data and CE/UKCA marking to cybersecurity credentials and alignment with frameworks like DTAC (Digital Technology Assessment Criteria) —is perfectly aligned.
Local Engagement Support: For direct approaches to Trusts and ICBs, we help you prepare tailored value propositions that demonstrate clear clinical and economic impact, enabling successful pilots and early adoption.

Optimize Revenue: Pricing Strategies and Advisory Boards

A product’s success often comes down to its price and the strategic guidance behind it. The pain is misjudging payer expectations or lacking access to the Key Opinion Leaders (KOLs) who validate your strategy.

Strategic Pricing Development: We specialize in developing pricing strategies—including value-based, subscription (SaaS), or bundled models—that align with complex payer, provider, and patient expectations in the healthcare sector. We also offer guidance on US reimbursement to assess coverage potential.
Access to Clinical KOLs: Leverage our extensive clinical networks to build a high-impact Advisory Board. We help you connect with clinical and operational leaders who can provide crucial insights on product development, go-to-market strategies, and expansion into new markets, filling essential gaps in your operational expertise.

To find out more about UK market access, from regulation to procurement, join our ‘Selling to the NHS’ regular webinar. Register via the link below.